BioSpace News Archive

Veru Inc. announced the granting of inducement awards to seven new employees.

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to four new employees to purchase an aggregate of 58,300 shares of the Company’s common stock, effective as of October 3, 2022.

Ultragenyx Pharmaceutical Inc. reported the grant of non-qualified stock options to purchase an aggregate of 13,000 shares of common stock of the company and 6,500 restricted stock units of the company’s common stock to one newly hired non-executive officer of the company.

BioCareSD, a specialty distributor of life-saving therapies, today announced a contract with UCB to add six new product offerings to its already diverse portfolio

Secretome Therapeutics, a preclinical company developing novel therapies derived from neonatal mesenchymal stem cells, announced the appointment of Angela Shen, M.D., M.B.A, to its Board of Directors.

Paradigm Biopharmaceuticals Ltd (ASX:PAR) (Paradigm or the Company), a latestage drug development company focused on delivering new therapies to address unmet medical needs, is pleased to announce that the primary endpoint has been met and additionally significant improvement in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores were demonstrated for injectable iPPS in the PARA_OA_008 phase 2 clinical trial.

OncoSec Medical Incorporated announced a corporate restructuring intended to prioritize development of its lead clinical candidate TAVO™ a plasmid encoding interleukin 12 delivered by intratumoral electroporation, and extend the Company’s cash runway.

Sensient Technologies Corporation announced that it has acquired Endemix Doğal Maddeler A.Ş. Endemix, located in Turkey, is a vertically integrated natural color and extracts company servicing the food and beverage markets.

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on October 3, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 26,875 shares of Puma common stock to five new non-executive employees.

Aurora Spine Corporation announced it has received 510 clearance from the United States Food and Drug Administration for the patented minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System.